Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · IEX Real-Time Price · USD
4.630
-0.130 (-2.73%)
At close: Jul 19, 2024, 4:00 PM
4.580
-0.050 (-1.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Achieve Life Sciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ACHV stock have an average target of 14, with a low estimate of 11 and a high estimate of 20. The average target predicts an increase of 202.38% from the current stock price of 4.63.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2024.
Analyst Ratings
The average analyst rating for ACHV stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $18 → $11 | Buy | Maintains | $18 → $11 | +137.58% | May 13, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +331.97% | Apr 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $18 | Buy | Reiterates | $18 | +288.77% | Apr 1, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $19 → $11 | Strong Buy | Maintains | $19 → $11 | +137.58% | Mar 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +288.77% | Dec 12, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.10
from -1.50
EPS Next Year
-0.95
from -1.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 76.7M | 199.6M | 336.1M |
| Avg | n/a | n/a | 41.6M | 126.5M | 245.4M |
| Low | n/a | n/a | 5.5M | 49.7M | 103.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 379.4% | 165.8% |
| Avg | - | - | - | 203.7% | 94.0% |
| Low | - | - | - | 19.2% | -18.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.89 | -0.75 | 0.37 | 2.30 | 3.90 |
| Avg | -1.10 | -0.95 | -0.02 | 1.40 | 3.18 |
| Low | -1.31 | -1.09 | -0.49 | 0.54 | 2.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 178.8% |
| Avg | - | - | - | - | 127.4% |
| Low | - | - | - | - | 76.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.